
    
      A randomised, open label, five-way crossover study to assess the systemic exposure of
      fluticasone propionate and salmeterol from SERETIDE™/ADVAIR™ 250 HFA MDI without spacer and
      with AeroChamber-Max spacer and VOLUMATIC™ both in their washed and unwashed states in adult
      subjects with mild or intermittent asthma.
    
  